Grantham, Mayo, Van Otterloo & Co (GMO)’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-25,295
Closed -$541K 694
2013
Q3
$541K Sell
25,295
-17,915
-41% -$368K ﹤0.01% 540
2013
Q2
$836K Buy
+43,210
New +$943K ﹤0.01% 483

Other funds holding PTEN

Grantham, Mayo, Van Otterloo & Co (GMO)'s PTEN Position: Q4 2013 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Patterson-UTI (PTEN) in Q4 2013, closing a stake of 25,295 shares — an estimated $541K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PTEN in Q2 2013 and held it in 2 quarters. The position peaked at $836K in Q2 2013. 274 funds tracked by Wall St. Rank hold PTEN as of Q4 2013.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Patterson-UTI position as of Q4 2013 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 25,295 Patterson-UTI shares in Q4 2013, an estimated $541K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Patterson-UTI in Q2 2013 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Patterson-UTI position peaked at $836K in Q2 2013.
  • 274 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2013.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2013, filed 13 Feb 2014.